Noetica Pharma Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Noetica Pharma General Information
Description
Developer of neuroprotective drug therapies designed for neonatal hypoxic-ischemic encephalopathy. The company's lead candidate is a patented small molecule that utilizes a multimodal mechanism to reduce oxidative stress and neuroinflammation, enabling healthcare providers to treat newborns affected by oxygen deprivation at birth and prevent long-term neurological disabilities.
Contact Information
Website
www.noetica-pharma.comCorporate Office
- France
Corporate Office
- France
Noetica Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Nov-2026 | Completed | Generating Revenue |
Noetica Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TechnoFounders | Venture Capital | Minority |
Noetica Pharma FAQs
-
When was Noetica Pharma founded?
Noetica Pharma was founded in 2025.
-
Where is Noetica Pharma headquartered?
Noetica Pharma is headquartered in France.
-
What industry is Noetica Pharma in?
Noetica Pharma’s primary industry is Other Healthcare Technology Systems.
-
Is Noetica Pharma a private or public company?
Noetica Pharma is a Private company.
-
What is Noetica Pharma’s current revenue?
The current revenue for Noetica Pharma is .
-
Who are Noetica Pharma’s investors?
TechnoFounders has invested in Noetica Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process